BSECompany Update▲ PositiveResults28 Oct 2026
Waaree Energies Ltd
Investor Presentation for Investor/Earning''s call for the Financial Results for the Quarter and half Year ended September 30, 2026.
Waaree Energies Ltd has released its Q2 and H1 FY27 earnings presentation, highlighting a 24% YoY revenue growth, 17.8% operating EBITDA margin, and 9.8% profit after tax margin. The company has a diversified revenue mix, with a strong retail growth of 27.4% YoY. The order book stands at ~26 GW, with a module capacity of ~5.4 GW and a net debt of ₹-3,224 Cr.
NSEPress Release▲ PositiveResults28 Oct 2026
ROUTE MOBILE LIMITED
Press Release
Route Mobile Limited has announced its Q2FY27 results, with revenue from operations standing at Rs. 1,179.67 crore, PAT at Rs. 82.55 crore, and EPS at Rs. 12.63.
NSEPress Release▲ PositiveResults27 Oct 2026
Sterling Tools Limited
Press Release
Sterling Tools Limited reported its unaudited financial results for Q2 and H1 FY27, with a 28.2% YoY growth in standalone half-yearly top-line and a 32.4% YoY growth in Q2 standalone top-line, outpacing industry growth. The company achieved its highest-ever half-yearly and quarterly top-line and EBITDA, driven by stronger traction in the commercial vehicle segment and higher volumes.
BSECompany Update▲ PositiveResults27 Oct 2026
Sterling Tools Ltd-$
Please find attached the Press Release on Unaudited Financial Results for Second Quarter and Half Year ended 30th September, 2026
Sterling Tools Ltd reported its highest-ever standalone half-yearly top-line and EBITDA, with a 28.2% YoY growth in total income and 17.3% YoY growth in EBITDA. The company outperformed industry growth on both a quarterly and half-yearly basis, driven by stronger traction in the commercial vehicle segment and higher volumes.
NSEInvestor Presentation▲ PositiveResults27 Oct 2026
LT Foods Limited
Investor Presentation
LT Foods Limited has released its Investor Presentation for the quarter and half year ended September 30, 2026, highlighting double-digit growth, a net-cash balance sheet, and brands scaling globally.
NSEPress Release▲ PositiveResults27 Oct 2026
Unimech Aerospace and Manufacturing Limited
Press Release
Unimech Aerospace and Manufacturing Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with revenue surging 98% YoY to ₹1,230 Mn, EBITDA up 164% YoY, and PAT up 103% YoY.
BSECompany Update▲ PositiveResults27 Oct 2026
Unimech Aerospace and Manufacturing Ltd
Please find enclosed the press release dated October 27th, 2026 on the Financial Results of the Company for the quarter and half year ended September 30, 2026.
Unimech Aerospace and Manufacturing Ltd reported Q2 FY27 financial results with revenue surging 98% YoY to ₹1,230 Mn, EBITDA up 164% YoY, and PAT up 103% YoY. The company's consolidated order book stood at ₹8,546 Mn, up 8-times YoY.
BSECompany Update▲ PositiveResults27 Oct 2026
LT Foods Ltd
Investor Presentation for Q2 H1 Q27
LT Foods Ltd has reported a 22% YoY growth in revenue and 17% YoY growth in EBITDA for H1 FY27, with a net-cash balance sheet and brands scaling globally. The company has also seen a 40 bps increase in ROCE and a 31-day reduction in working capital days.
BSECompany Update▲ PositiveResults27 Oct 2026
Unimech Aerospace and Manufacturing Ltd
Please find enclosed the copy of Earnings Presentation on Un-audited Financial Results of the Company for the quarter and half year ended September 30, 2026, to be made to analysts/investors.
Unimech Aerospace and Manufacturing Ltd has announced its un-audited financial results for the quarter and half year ended September 30, 2026, with revenue reaching Rs.2,306 Mn, representing an 85% year-on-year growth. The company has secured a 10-year LTA with Honeywell Aerospace and a ~USD43mn award letter from a French Tier-1 aerospace company. The automated special-process cell installation is underway, and the Middle East expansion via the Saudi Arabia JV is progressing.
BSECompany Update▲ PositiveResults27 Oct 2026
Siyaram Silk Mills Ltd-$
Investor Presentation on Unaudited Financial Results for quarter and half year ended on 30th September 2026
Siyaram Silk Mills Ltd has released an investor presentation for its unaudited financial results for Q2 and H1 FY27, showing a 15.1% YoY increase in total income to ₹827 crores and a 8.0% YoY increase in EBITDA to ₹131 crores.
BSECompany Update▲ PositiveResults27 Oct 2026
Waaree Energies Ltd
Press release for the Unaudited Financial Results (Standalone and Consolidated) For the quarter and half year ended September 30, 2026.
Waaree Energies Ltd reported strong revenue growth, robust EBITDA, and profitability in H1 FY27, with revenue up 47.3% YoY to ₹15,449.5 Crores and EBITDA up 15.5% YoY to ₹2,775.1 Crores. The company also announced plans to expand its Meyer Berger facility in the US and commenced production of automated BESS containers in Gujarat.
NSEPress Release▲ PositiveResults27 Oct 2026
Waaree Energies Limited
Press Release
Waaree Energies Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, reporting a 47.3% year-on-year growth in revenue to ₹15,449.5 Crores, with EBITDA up 15.5% YoY and PAT margin at 15.3%. The company has also announced plans to expand its Meyer Berger facility in Arizona, USA, and has commenced advanced 5.15 GWh of automated BESS container manufacturing in Rola, Gujarat.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults27 Oct 2026
Piramal Pharma Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Piramal Pharma Limited has announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
BSECompany Update▲ PositiveResults27 Oct 2026
Piramal Pharma Ltd
Please find enclosed Investor presentation for quarter ended 30 September, 2026
Piramal Pharma Ltd announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
NSEInvestor Presentation▲ PositiveResults27 Oct 2026
Piramal Pharma Limited
Investor Presentation
Piramal Pharma Limited has announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
NSEPress Release▲ PositiveResults27 Oct 2026
Piramal Pharma Limited
Press Release
Piramal Pharma Limited has announced its standalone and consolidated results for the Second Quarter (Q2) and Half Year (H1) ended 30th September 2026, with revenue growth of 28% YoY in Q2FY27 and 23% YoY in H1FY27, driven by strong performance across all three businesses.
BSECompany Update▲ PositiveResults27 Oct 2026
Piramal Pharma Ltd
Please find enclosed Press release for quarter ended 30 September, 2026
Piramal Pharma Ltd has announced its unaudited financial results for Q2 and H1 FY27, with revenue growth of 28% YoY and 23% YoY respectively, driven by strong performance across all three businesses. EBITDA increased 72% YoY in Q2FY27 and H1FY27, with over 350bps EBITDA margin expansion in both periods.
NSEPress Release▲ PositiveResults27 Oct 2026
SKY GOLD AND DIAMONDS LIMITED
Press Release
Sky Gold and Diamonds Limited has announced its Q2 and H1 FY27 financial results, with revenue at Rs. 4,403.45 Crore, PAT up 111.9%, and EBITDA margin at 7.87%.
BSECompany Update▲ PositiveResults27 Oct 2026
Siyaram Silk Mills Ltd-$
We enclose herewith Press Release dated 27th October 2026
Siyaram Silk Mills Ltd reported Q2 FY27 results with revenue up 15.1% y-o-y to ₹827 crores, EBITDA of ₹131 crores, and PAT of ₹75 crores. The company declared a first interim dividend of ₹4 per equity share.
BSECompany Update▲ PositiveResults27 Oct 2026
Syngene International Ltd
Press Release
Syngene International Ltd reported a 13% sequential revenue growth in Q2 FY27, with operating EBITDA margin improving by 6 percentage points. The company also announced a manufacturing agreement for its Bayview biologics facility in the U.S. and strengthened its integrated drug discovery offering.